Cargando…
Immune Checkpoint Inhibitor-Induced Hemorrhagic Gastritis
Immune checkpoint inhibitors (ICIs) have been increasingly used in the treatment of several malignancies and may target cytotoxic T-lymphocyte-associated antigen-4, programmed cell death-1, and programmed cell death ligand 1, which work on maintaining peripheral immune tolerance. ICIs inhibit these...
Autores principales: | Mathialagan, Karthik, Tai, Cheng-Hung, Sethi, Samdish, Thomas, Sumi, Loeser, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424893/ https://www.ncbi.nlm.nih.gov/pubmed/37583508 http://dx.doi.org/10.14309/crj.0000000000001128 |
Ejemplares similares
-
Combination Checkpoint Inhibitor-Induced Hemorrhagic Gastritis
por: Bazarbashi, Ahmad Najdat, et al.
Publicado: (2020) -
Isolated Gastritis Secondary to Immune Checkpoint Inhibitors Complicated by Superimposed Cytomegalovirus Infection
por: Nguyen, Anita H., et al.
Publicado: (2022) -
Immune checkpoint inhibitor‐related gastritis in a patient with metastatic melanoma
por: Sugiyama, Yuya, et al.
Publicado: (2021) -
Temporal observation of endoscopic and histological findings of gastritis after administration of an immune checkpoint inhibitor: a case report
por: Saito, Keita, et al.
Publicado: (2022) -
Severe acute gallstone pancreatitis with diffuse hemorrhagic gastritis
por: Harris, Timothy J, et al.
Publicado: (2018)